Cardiol Therapeutics Inc. (CRDL.TO)
CAD 1.58
(3.95%)
CAD 1.58
(3.95%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -34.77 Million CAD | 41.46% |
| 2022 | -59.39 Million CAD | 29.1% |
| 2021 | -83.78 Million CAD | -504.11% |
| 2020 | -13.86 Million CAD | -104.99% |
| 2019 | -6.76 Million CAD | 58.9% |
| 2018 | -16.46 Million CAD | -659.86% |
| 2017 | -2.16 Million CAD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -23.85 Million CAD | 16.01% |
| 2024 Q1 | -28.4 Million CAD | 18.13% |
| 2023 Q4 | -34.69 Million CAD | 14.03% |
| 2023 Q2 | -44.89 Million CAD | 9.13% |
| 2023 Q1 | -49.4 Million CAD | 16.82% |
| 2023 FY | -34.69 Million CAD | 41.59% |
| 2023 Q3 | -40.35 Million CAD | 10.1% |
| 2022 Q2 | -70.35 Million CAD | 5.86% |
| 2022 Q4 | -59.39 Million CAD | 9.25% |
| 2022 FY | -59.39 Million CAD | 29.1% |
| 2022 Q1 | -74.73 Million CAD | 10.8% |
| 2022 Q3 | -65.44 Million CAD | 6.98% |
| 2021 Q1 | -17.85 Million CAD | -28.76% |
| 2021 FY | -83.78 Million CAD | -504.11% |
| 2021 Q4 | -83.78 Million CAD | -193.71% |
| 2021 Q3 | -28.52 Million CAD | 12.45% |
| 2021 Q2 | -32.58 Million CAD | -82.46% |
| 2020 Q1 | -4.31 Million CAD | 36.23% |
| 2020 FY | -13.86 Million CAD | -104.99% |
| 2020 Q4 | -13.86 Million CAD | 15.34% |
| 2020 Q3 | -16.38 Million CAD | 14.95% |
| 2020 Q2 | -19.25 Million CAD | -346.43% |
| 2019 Q4 | -6.76 Million CAD | 31.7% |
| 2019 Q2 | -12.25 Million CAD | 14.29% |
| 2019 Q1 | -14.29 Million CAD | 13.17% |
| 2019 FY | -6.76 Million CAD | 58.9% |
| 2019 Q3 | -9.9 Million CAD | 19.15% |
| 2018 Q4 | -16.46 Million CAD | -1903.18% |
| 2018 Q1 | 2.35 Million CAD | 208.77% |
| 2018 Q2 | -1.12 Million CAD | -147.83% |
| 2018 FY | -16.46 Million CAD | -659.86% |
| 2018 Q3 | 912.95 Thousand CAD | 181.01% |
| 2017 FY | -2.16 Million CAD | 0.0% |
| 2017 Q4 | -2.16 Million CAD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Aurora Cannabis Inc. | -8.64 Million CAD | -302.096% |
| Avicanna Inc. | 1.32 Million CAD | 2722.023% |
| Avant Brands Inc. | 17.93 Million CAD | 293.939% |
| Crescita Therapeutics Inc. | -8.13 Million CAD | -327.663% |
| Knight Therapeutics Inc. | 10.33 Million CAD | 436.624% |
| MediPharm Labs Corp. | -15.68 Million CAD | -121.683% |
| OrganiGram Holdings Inc. | -33.7 Million CAD | -3.157% |
| Canopy Growth Corporation | 512.87 Million CAD | 106.78% |
| Willow Biosciences Inc. | -989 Thousand CAD | -3416.001% |
| Auxly Cannabis Group Inc. | 142.88 Million CAD | 124.337% |